“Before settling on Jiahui, I received treatment proposals from hospitals in Saudi Arabia and the United States. I chose Jiahui for their prompt replies and efficient communication. This innovative solid‑tumor CAR‑T therapy was also the most accessible option for my condition,” Josh recalled. “I had never visited China before, so I was anxious. Fortunately, I met the Jiahui team, especially Dr. Xuan, who practiced medicine in the United States for two decades.

Recently, a delegation from Bangkok Hospital visited Jiahui Health, and the two sides held exchanges focusing on oncology diagnosis, treatment and innovation. The two sides focused on cutting-edge topics in clinical oncology – ranging from surgical operations to advanced and sophisticated therapies such as CAR-T, as well as the application practice of new anti-tumor drugs in China.